BIOMAT Database Logo BIOMAT Database Logo

[Thyroid function in diabetics treated with sulfonylurea and biguanides]. 1978

T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea
D013961 Thyroid Gland A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively. Thyroid,Gland, Thyroid,Glands, Thyroid,Thyroid Glands,Thyroids

Related Publications

T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
[Thyroid function in diabetics treated with sulfonylurea compounds].
October 1958, Archivio "E. Maragliano" di patologia e clinica,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
THE VISCERA IN SULFONYLUREA-TREATED DIABETICS.
November 1963, Metabolism: clinical and experimental,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
Biguanides and lactic acidosis in diabetics.
January 1978, British medical journal,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
Biguanides and lactic acidosis in diabetics.
December 1977, British medical journal,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
[Simplified combination treatment of diabetes mellitus with sulfonylurea compounds and biguanides].
January 1975, Zeitschrift fur Allgemeinmedizin,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
[Blood coagulation, fibrinolysis and kallikreinogenesis in diabetics with vascular complications treated with insulin or sulfonylurea derivatives].
July 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
November 1972, Arzneimittel-Forschung,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
[Lactic acidosis in diabetics on biguanides (author's transl)].
January 1977, Deutsche medizinische Wochenschrift (1946),
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
[Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
June 1980, La Clinica terapeutica,
T Kasperska-Czyzykowa, and W Czech, and Z Sawicki, and J Woy-Wojciechowski, and W Zuławnik
[ON THE ACTION OF LIPOPROTEINS IN DIABETICS UNDER TREATMENT WITH BIGUANIDES].
October 1964, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!